Evaluation of focal hepatic lesions with ultrasound contrast agents

Journal of Clinical Ultrasound

Volumn 39, Issue 7, 2011, Pages 399-407

  Sutherland, Tom ^a   Temple, Faye ^a   Lee, Wai Kit ^a   Hennessy, Oliver ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Liver; Neoplasms; Ultrasonography; Ultrasound contrast agents

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT;

CYST; DIFFERENTIAL DIAGNOSIS; DOPPLER FLOWMETRY; ECHOGRAPHY; EVALUATION; FATTY LIVER; FEMALE; HEMANGIOMA; HUMAN; IMAGE ENHANCEMENT; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER TUMOR; MALE; METHODOLOGY; NODULAR HYPERPLASIA; REVIEW; SENSITIVITY AND SPECIFICITY;

CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; CYSTS; DIAGNOSIS, DIFFERENTIAL; FATTY LIVER; FEMALE; FOCAL NODULAR HYPERPLASIA; HEMANGIOMA; HUMANS; IMAGE ENHANCEMENT; LIVER ABSCESS; LIVER DISEASES; LIVER NEOPLASMS; MALE; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER;

EID: 79961209173     PISSN: 00912751     EISSN: 10970096     Source Type: Journal    
DOI: 10.1002/jcu.20847     Document Type: Article

References (25)

1. Bolondi L, Correas JM, Lencioni R, et al. New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice. Digestive Liver Dis 2007; 39: 187.
2. EFSUMB Study Group. Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS)-Update 2008. Ultraschall in Med 2008; 29: 28.
3. Correas JM, Bridal L, Lesavre A, et al. Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol 2001; 11: 1316.
4. Quaia E, D'Onofrio M, Palumbo A, et al. Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur Radiol 2006; 16: 1599.
5. Chami L, Lassau N, Malka D, et al. Benefits of contrast-enhanced sonography for the detection of liver lesions: Comparison with histologic findings. AJR Am J Roentgenol 2008; 190: 683.
6. Quala E, Calliada F, Bertolotto M, et al. Characterization of focal liver lesions with contrast-specific US modes and a sulphur hexafluoride-filled microbubble contrast agent: Diagnostic performance and confidence. Radiology 2004; 232: 420.
7. Knopke R, Kersting S, Bergert H, et al. Contrast-enhanced ultrasonography to detect liver metastases. Int J Colorectal Dis 2007; 22: 201.
8. Moriyasu F, Itoh K. Efficacy of perflubutane mcrobubble-enhanced ultrasound in the characterization and detection of focal liver lesions: Phase 3 multicenter clinical trial. AJR Am J Roentgenol 2009; 193: 86.
9. Schwartz LH, Gandras EJ, Colangelo SM, et al. Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 1999; 210: 75.
10. Strobel D, Seitz K, Blank W, et al. Contrast-enhanced ultrasound for the characterization of focal liver lesions-Diagnostic accuracy in clinical practice (DEGUM multicenter trial). Ultraschall Med 2008; 29: 499.
11. Tranquart F, Le Gouge A, Correas JM, et al. Role of contrast-enhanced ultrasound in a blinded assessment of focal liver lesions in comparison with MDCT and CEMRI: Results from a multicentre clinical trial. Eur J Cancer Supp 2008; 6: 9.
12. Trillaud H, Bruel JM, Valette PJ, et al. Characterisation of focal liver lesions with SonoVue-enhanced sonography: International multicenter-study in comparison to CT and MRI. World J Gastroenterol 2009; 15: 3748.
13. Soussan M, Aube C, Bahrami S, et al. Incidental focal solid liver lesions: diagnostic performance of contrast-enhanced ultrasound and MR imaging. Eur Radiol 2010; 20: 1715.
14. Wilson SR, Burns PN. An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography. AJR Am J Roentgenol 2006; 186: 1401.
15. Bhayana D, Kim TK, Jang HJ. Hypervascular liver masses on contrast-enhanced ultrasound: The importance of washout. AJR Am J Roentgenol 2010; 194: 977.
16. Berry JD, Boxer ME, Rashid HI, et al. Case report: Microbubble contrast-enhanced ultrasound characteristics of multiple biliary hamartomas (von Meyenberg complexes). Ultrasound 2004; 12: 95.
17. Murphy-Lavallee J, Jang HJ, Kim TK, et al. are metastases really hypovascular in the arterial phase? The perspective based on contrast-enhanced ultrasonography. J Ultrasound Med 2007; 26: 1545.
18. Jang HJ, Kim TK, Burns PN, et al. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: Comparison with histologic differentiation. Radiology 2007; 244: 898.
19. Jang HJ, Kim TK, Wilson SR. Small nodules (1-2 cm) in liver cirrhosis: Characterization with contrast-enhanced ultrasound. Eur J Radiol 2009; 72: 418.
20. Nicolau C, Catala V, Vilana R, et al. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 2004; 14: 1092.
21. Liu GJ, Lu MD, Xie XY, et al. Real-time contrast-enhanced ultrasound imaging of infected focal liver lesions. J Ultrasound Med 2008; 27: 657.
22. Bartolotta TV, Midiri M, Quaia E, et al. Liver haemangiomas undetermined at grey-scale ultrasound: contrast-enhancement patterns with SonoVue and pulse-inversion US. Eur Radiol 2005; 15: 685.
23. Bartolotta TV, Taibbi A, Galia M, et al. Centrifugal (inside-out) enhancement of liver hemangiomas: A possible atypical appearance on contrast-enhanced US. Eur J Radiol 2007; 64: 447.
24. Kim MJ, Lim HK, Kim SH, et al. Evaluation of hepatic focal nodular hyperplasia with contrast-enhanced gray-scale harmonic sonography. J Ultrasound Med 2004; 23: 297.
25. Kim TK, Jang HJ, Burns PN, et al. Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sonography. AJR Am J Roentgenol 2008; 190: 58.